Emergency Use Authorization (EUA) for the company’s SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system.

Abbott gets FDA EUA for COVID-19 antibody blood test on Alinity i system

Abbott gets FDA EUA for COVID-19 antibody blood test on Alinity i system

ABBOTT PARK, Ill. —  Abbott announced on Monday  that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company’s SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system. Abbott plans to ship nearly 30 million antibody tests globally in May across its ARCHITECT and Alinity i platforms and